News Altimmune, Inc.

Equities

ALT

US02155H2004

Real-time Estimate Cboe BZX Other stock markets 10:27:07 2024-05-09 am EDT			5-day change	1st Jan Change
7.76 ^USD	+8.38%		+10.71%	-29.24%

01:09pm	Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000	MT
Apr. 30	North American Morning Briefing : More Earnings -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000	07:09am	MT
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update	07:02am	AQ
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ALT	10:31pm	PR
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors	May. 08	BU
ALT Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	May. 07	PR
Law Offices of Howard G. Smith Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors	May. 07	BU
The Law Offices of Frank R. Cruz Announces Investigation of Altimmune, Inc. (ALT) on Behalf of Investors	May. 07	BU
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALT	May. 07	BU
Altimmune to Participate at Two Upcoming Investor Conferences	May. 07	AQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Altimmune, Inc. and Certain Officers - ALT	May. 06	PR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune	May. 06	PR
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024	May. 02	AQ
Altimmune to Participate at Two Upcoming Conferences	May. 01	AQ
North American Morning Briefing : More Earnings -2-	Apr. 30	DJ
Altimmune Shares Decline After Guggenheim Downgrade	Apr. 29	MT
Guggenheim Downgrades Altimmune to Neutral From Buy	Apr. 29	MT
Altimmune Statement on the Passing of Dr. Stephen Harrison	Apr. 25	AQ
Transcript : Altimmune, Inc. - Special Call	Apr. 02
Altimmune Shares Slip Wednesday, After Reporting a Wider Q4 Net Loss and Dropping Prospective Treatment for Hepatitis B	Mar. 27	MT
Transcript : Altimmune, Inc., Q4 2023 Earnings Call, Mar 27, 2024	Mar. 27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Altimmune, Inc.

Equities

ALT

US02155H2004

Summary

Filters